Age and stage specific prevalence estimate of cancer from population based Cancer Registry using inhomogeneous poisson process

Statistical Methods in Medical Research

Volumn 13, Issue 4, 2004, Pages 273-289

  Gras, Claudine ^a   Daures J P ^a,b   Tretarre, B ^b  

^a UNIV MONTPELLIER   (France)

^b Registre des Tumeurs de l'Herault   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; FEMALE; FRANCE; GROUPS BY AGE; HUMAN; MATHEMATICAL COMPUTING; PARAMETRIC TEST; POISSON DISTRIBUTION; POPULATION RESEARCH; PREVALENCE; PROBABILITY; REVIEW; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 4344704653     PISSN: 09622802     EISSN: None     Source Type: Journal    
DOI: 10.1191/0962280204sm366ra     Document Type: Review

References (17)

1. Byrne J, Kessler LG, Devesa SS. The prevalence of cancer among adults in the United States. Cancer 1992; 68: 2154-59.
2. Feldman AR, Kessler L, Myers MH, Naughton MD. The prevalence of cancer. Estimates based on the Connecticut Tumor Registry. New England Journal of Medicine 1986; 315: 1394-97.
3. Gail MH, Kessler L, Midthune D, Scoppa S. Two approaches for estimating disease prevalence from population-based registries of incidence and total mortality. Biometrics 1999; 55: 1137-44.
4. Capocaccia R, De Angelis R. Estimating the completeness of prevalence based on cancer registry data. Statistics in Medicine 1997; 16: 425-40.
5. Merrill RM, Capocaccia R, Feuer EJ, Mariotto A. Cancer prevalence estimates based on tumor registry data in the SEER program. International Journal of Epidemiology 2000; 29: 197-207.
6. Verdecchia A, Capocaccia R. A method for the estimation of chronic disease morbidity and trends from mortality data. Statistics in Medicine 1989; 8: 201-16.
7. Capocaccia R. Relationships between incidence and mortality in non-reversible diseases. Statistics in Medicine 1993; 12: 2395-415.
8. Keiding N. Age-specific incidence and prevalence: a statistical perspective. Journal of the Royal Statistical Society, Series A 1991; 154: 371-412.
9. Capocaccia R, Colonna M, Corazziari I, De Angelis R, Francisci S, Mocheli A, Mugno E and the EUROPREVAL Working Group. Measuring cancer prevalence in Europe: the EUROPREVAL project. Annals of Oncology 2002; 13: 831-39.
10. Micheli A, Mugno E, Krogh V, Quinn MJ, Coleman M, Hakulinen T, Gatta G, Berrino F, Capocaccia R and the EUROPREVAL Working Group. Cancer prevalence in European registry areas. Annals of Oncology 2002; 13: 840-65.
11. Brillinger DR. The natural variability of vital rates and associated statistics (with discussion). Biometrics 1986; 42: 693-734.
12. Keiding N. Statistical inference in the Lexis diagram. Philosophical Transactions of the Royal Society London A 1990; 332: 487-509.
13. DeGroot MH, Ferber R, Frankel MR, Seneta E, Watson GS. Encyclopedia of statistical sciences. Chichester: John Wiley & Sons: 1988, 8: 646-47.
14. Dodge Y. Statistique dictionnnaire encyclopédique. Paris: Dunod, 1993: 61.
15. Colonna M, Hedelin G, Estève J, Grosclaude P, Launoy G, Buémi A, Arveux P, Tretarre B, Chaplain G, Macé Lesec'h J, Raverdy N, Carli PM, Menegoz F, Faivre J. National cancer prevalence estimate in France. International Journal of Cancer 2000; 87: 301-304.
16. Ménégoz F, Chérié-Challine L, Grosclaude P, Jougla E. Réseau français des registres des cancers FRANCIM. Le Cancer en France: incidence et mortalité: situation en 1995, évolution entre 1975 et 1995. Paris: Broché, 1998.
17. Micheli A, Francisci S, Krogh V, Rossi AG, Crosignani P for the ITAPREVAL Working Group. Cancer prevalence in Italian cancer registry areas: the ITAPREVAL study. Tumori 1999; 85: 309-69.